Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...

Phibro Animal Health just received a new price target, marking a fresh chapter in how the stock is being framed by analysts ...

TEANECK, N.J.--(BUSINESS WIRE)--(NASDAQ: PAHC) The Food and Drug Administration (FDA), through its Center for Veterinary Medicine (CVM), has taken two actions regarding Mecadox ® (carbadox), a drug ...

JPMorgan upgraded Phibro Animal Health Corporation (NASDAQ:PAHC), citing strong execution following its $350 million acquisition of Zoetis' medicated feed additive and water-soluble product portfolio.

Animal health products manufacturer Phibro Animal Health (NASDAQ:PAHC) fell short of the markets revenue expectations in Q1 CY2026, with sales flat year on year at $347.8 million. On the other hand, ...

Wondering if Phibro Animal Health is still a smart buy after its big run, or if the easy money has already been made? Here is a breakdown of whether the current price really matches the underlying ...

Phibro Animal Health PAHC has seen impressive momentum in the past year, with its shares soaring 82.8%. It has significantly outperformed the 9.6% rise of the industry and the S&P 500 Composite’s 26.7 ...

Phibro Animal Health Corp. entered into a definitive agreement to acquire Zoetis Inc.’s medicated feed additive product portfolio for $350 million. The New Jersey-based companies announced the ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to ...